Pituitary adenoma: important genetic factors and clinical diagnostic issues

Pituitary adenoma (PA) is a benign tumor of parenchymal cells in the adenohypophysis. Clinically significant PA occurs in 1 in 1064 of the population. Invasive PAs, pituitary carcinomas, are aggressive and can spread from sella turcica to other tissues. PA invasiveness and tumor-caused metabolic di...

Full description

Saved in:
Bibliographic Details
Main Authors: G. Juknytė, E. Karinauskė, R. Liutkevičienė
Format: Article
Language:English
Published: Vilnius University Press 2021-06-01
Series:Neurologijos seminarai
Subjects:
Online Access:https://www.journals.vu.lt/neurologijos_seminarai/article/view/27613
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832593067905908736
author G. Juknytė
E. Karinauskė
R. Liutkevičienė
author_facet G. Juknytė
E. Karinauskė
R. Liutkevičienė
author_sort G. Juknytė
collection DOAJ
description Pituitary adenoma (PA) is a benign tumor of parenchymal cells in the adenohypophysis. Clinically significant PA occurs in 1 in 1064 of the population. Invasive PAs, pituitary carcinomas, are aggressive and can spread from sella turcica to other tissues. PA invasiveness and tumor-caused metabolic disorders can also be fatal, as almost every human organ and tissue is directly or indirectly affected by hormones secreted by the anterior or posterior pituitary gland. Most PAs occur spontaneously and their origin is not well known. It is thought to be a disease of multifactorial etiology, the occurrence of which is influenced by genetic factors, hormonal stimulation, and growth factors. PA can be inherited in an autosomal dominant manner. Recently, many new genetic alterations have been identified that make people predisposed to pituitary adenomas. Attempts are also being made to find new molecular diagnostic and prognostic targets that would contribute to more effective treatment of pituitary adenomas. Since the development of pituitary adenomas can be significantly influenced by epigenetic changes in pituitary cells, there is currently an increasing focus on the study of epigenetic mechanisms such as DNA methylation, histone modifications, and micro-RNA studies. Analysis of mRNA expression is also performed to assess the decrease or increase in gene expression in the case of pathology. All of these studies are aimed at finding new molecular markers for the development of targets for the treatment of pituitary adenomas. Therefore, in this article, we review the genetic issues of pituitary adenoma.
format Article
id doaj-art-65659f6635884eeb9dd5574fd8d75f9b
institution Kabale University
issn 1392-3064
2424-5917
language English
publishDate 2021-06-01
publisher Vilnius University Press
record_format Article
series Neurologijos seminarai
spelling doaj-art-65659f6635884eeb9dd5574fd8d75f9b2025-01-20T18:22:27ZengVilnius University PressNeurologijos seminarai1392-30642424-59172021-06-01252(88)10.29014/ns.2021.10Pituitary adenoma: important genetic factors and clinical diagnostic issuesG. Juknytė 0E. Karinauskė1R. Liutkevičienė 2Lithuanian University of Health SciencesLithuanian University of Health SciencesLithuanian University of Health Sciences Pituitary adenoma (PA) is a benign tumor of parenchymal cells in the adenohypophysis. Clinically significant PA occurs in 1 in 1064 of the population. Invasive PAs, pituitary carcinomas, are aggressive and can spread from sella turcica to other tissues. PA invasiveness and tumor-caused metabolic disorders can also be fatal, as almost every human organ and tissue is directly or indirectly affected by hormones secreted by the anterior or posterior pituitary gland. Most PAs occur spontaneously and their origin is not well known. It is thought to be a disease of multifactorial etiology, the occurrence of which is influenced by genetic factors, hormonal stimulation, and growth factors. PA can be inherited in an autosomal dominant manner. Recently, many new genetic alterations have been identified that make people predisposed to pituitary adenomas. Attempts are also being made to find new molecular diagnostic and prognostic targets that would contribute to more effective treatment of pituitary adenomas. Since the development of pituitary adenomas can be significantly influenced by epigenetic changes in pituitary cells, there is currently an increasing focus on the study of epigenetic mechanisms such as DNA methylation, histone modifications, and micro-RNA studies. Analysis of mRNA expression is also performed to assess the decrease or increase in gene expression in the case of pathology. All of these studies are aimed at finding new molecular markers for the development of targets for the treatment of pituitary adenomas. Therefore, in this article, we review the genetic issues of pituitary adenoma. https://www.journals.vu.lt/neurologijos_seminarai/article/view/27613pituitary adenomagenebiomarkers
spellingShingle G. Juknytė
E. Karinauskė
R. Liutkevičienė
Pituitary adenoma: important genetic factors and clinical diagnostic issues
Neurologijos seminarai
pituitary adenoma
gene
biomarkers
title Pituitary adenoma: important genetic factors and clinical diagnostic issues
title_full Pituitary adenoma: important genetic factors and clinical diagnostic issues
title_fullStr Pituitary adenoma: important genetic factors and clinical diagnostic issues
title_full_unstemmed Pituitary adenoma: important genetic factors and clinical diagnostic issues
title_short Pituitary adenoma: important genetic factors and clinical diagnostic issues
title_sort pituitary adenoma important genetic factors and clinical diagnostic issues
topic pituitary adenoma
gene
biomarkers
url https://www.journals.vu.lt/neurologijos_seminarai/article/view/27613
work_keys_str_mv AT gjuknyte pituitaryadenomaimportantgeneticfactorsandclinicaldiagnosticissues
AT ekarinauske pituitaryadenomaimportantgeneticfactorsandclinicaldiagnosticissues
AT rliutkeviciene pituitaryadenomaimportantgeneticfactorsandclinicaldiagnosticissues